Signal transducer and activator of transcription 3 (STAT3), which mediates biological actions in many physiological processes, is activated by cytokines and growth factors via specific tyrosine phosphorylation, dimerization and nuclear translocation. To clarify the molecular mechanisms underlying the regulation of STAT3 activation, we performed yeast two-hybrid screening. We identified Y14, an RNA-binding protein, as a novel STAT3-binding partner. Y14 bound to STAT3 through the C-terminal region of STAT3 in vivo. Importantly, small-interfering RNA-mediated reduction of endogenous Y14 expression decreased IL-6-induced tyrosine-phosphorylation, nuclear accumulation and DNA binding activity of STAT3, as well as IL-6/STAT3-dependent gene expression.
Introduction
The Jak/STAT pathways are utilized by a wide range of cytokines to regulate gene expression. Cytokines activate members of the Jak family of protein tyrosine kinases, which in turn activate, by tyrosine phosphorylation, one or more members of the STAT family of transcription factors. STATs are unusual among transcription factors in that they have the characteristics of cytoplasmic signaling molecules, such as a Srchomology 2 domain and tyrosine phosphorylation sites.
Upon tyrosine phosphorylation, the STATs dimerize through their phosphorylated SH2 domains and translocate to the nucleus [1, 2, 3] . In recent years, constitutive or dysregulated expression of STAT3 has been found in cancer cells and oncogene-transfected cells and shown to be involved in a wide range of diseases including autoimmune diseases [4] [5] [6] [7] .
Studies in Dictyostelium, Drosophila and zebrafish have also shown that the Jak/STAT pathway is required for a broad set of developmental processes, including cell proliferation, cell fate determination, cell migration, planar polarity, convergent extension and immunity [8, 9] . These findings imply that STAT activation must be 4 tightly regulated.
To investigate the specific regulatory mechanisms of STAT3, we sought to identify STAT3-interacting proteins using yeast two-hybrid screening with the C-terminal region of STAT3 as bait. We identified Y14, an RNA-binding protein, as a novel binding partner of STAT3. Y14 is an RNA-binding protein that binds preferentially to spliced mRNAs immediately upstream of the exon-exon junctions, and remains bound to the mRNA after nuclear export [10, 11] . Y14 binds to STAT3 through the C-terminal region of STAT3. Furthermore, small-interfering RNA-mediated reduction of endogenous Y14 expression decreased IL-6-induced tyrosine-phosphorylation, nuclear accumulation and DNA binding activity of STAT3, as well as IL-6/STAT3-dependent gene expression. Here, we show that Y14 is a STAT3 binding partner with a critical role in STAT3-mediated transcription.
Materials and Methods
Reagents and antibodies, Recombinant human IL-6 was a kind gift from Ajinomoto Co.
(Tokyo, Japan). Recombinant human LIF was purchased from INTERGEN (Purchase, NY). Epipote-tagged STAT3 and its mutants were previously described [12, 13] .
Epitope-tagged Y14 was generated by PCR and sequenced (primer sequences are available upon request). Anti-Myc, anti-GST, anti-STAT3, and Y14 antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-phospho-STAT3 Tyr705 (pSTAT3 Tyr705) was purchased from Cell Signaling Technologies (Beverly, MA).
Anti-Actin antibody from Chemicon (Temecula, CA).
Yeast two-hybrid screen, Gal4-STAT3 was constructed by fusing the coding sequence followed by addition of fresh medium containing 10% FCS as previously described [15] .
siRNAs targeting human Y14 used in this study was follows: siY14, 5'-GGGGUAUACUCUAGUUGATT-3'. Total RNAs were prepared by using Iso-Gen (Nippon Gene, Tokyo, Japan) and used in reverse transcription (RT)-PCR. RT-PCR was performed using RT-PCR high -Plus-Kit (TOYOBO, Tokyo, Japan) [18] . Primers used for RT-PCR were: Y14: 5'-AAGATTTCGCCATGGATGAG-3' (sense), 5'-ATCAAATCCTGGCCATTGAG-3' (antisense). Quantitative real-time PCR analyses of SOCS3 and C/EBPd as well as the control G3PDH mRNA transcripts were carried out using the assay-on-demandTM gene-specific fluorescently labeled TaqMan MGB probe in an ABI Prism 7000 sequence detection system.
Immunoprecipitation, immunoblotting and DNA binding assay, Immunoprecipitation
and Western blotting were performed as previously described [16] . The cells were harvested and lysed in lysis buffer (50 mM Tris-HCl, pH 7.4, 0.15 M NaCl, 1% NP-40, 1 mM sodium orthovanadate, 1 mM phenylmethylsulfonyl fluoride, and 10 mg /ml each of aprotinin, pepstatin, and leupeptin). The immunoprecipitates from cell lysates were resolved on SDS-PAGE and transferred to an Immobilon filter (Millipore; Bedford, MA), which was then immunoblotted with antibodies. To measure STAT3 DNA binding, cell extracts were treated with the immobilized STAT3 consensus or mutant oligonucleotide-Sepharose conjugate (Santa Cruz) as described previously [15] . The precipitates were subjected to Western blot analysis using anti-pSTAT3 antibody. An aliquot of TCL was blotted with anti-pSTAT3, anti-STAT3 or anti-Y14 antibody.
Indirect Immunofluorescence microscopy, Hep3B cells (5x10 4 ) seeded on a glass plate were fixed with 4 % paraformaldehyde and reacted with respective antibodies. The cells were then reacted with FITC-conjugated anti-rabbit IgG or rhodamine-conjugated anti-
Results and Discussion

Molecular interactions between STAT3 and Y14
To investigate the regulatory mechanisms of STAT3, we sought to identify STAT3-interacting proteins. We performed a yeast two-hybrid screen of a mouse embryo cDNA library using the C-terminal region of STAT3 (amino acids 494-750) as bait. (Fig. 1D ).
However, after IL-6 stimulation, STAT3 translocated into the nucleus and co-localized with Y14. Consistent with the in vivo interaction data presented above, these results suggest that activated STAT3 mainly interacts with Y14 in the nucleus.
Y14 is involved in tyrosine-phosphorylation, nuclear accumulation and DNA binding activity of STAT3
To assess the functional relevance of the interaction between STAT3 and Y14, we first examined whether reduction of Y14 expression affects IL-6-induced tyrosine- We further examined whether a reduction in Y14 expression affects the DNA binding activity of STAT3. As shown in Fig. 3A and B, IL-6-induced DNA binding activity of 
Y14 is involved in IL-6/STAT3-mediated gene expression
To finally clarify the physiological significance of the molecular interactions between STAT3 and Y14, we examined the effect of Y14 on STAT3 activity. To test whether 
Concluding remarks
We here demonstrated that Y14 is a STAT3 binding partner and that a reduction in the levels of endogenous Y14 decreases STAT3-mediated transactivation by influencing tyrosine-phosphorylation and nuclear accumulation of STAT3.
Recently, Y14 has been shown to form the Drosophila oskar mRNA localization complex and act as the nuclear shuttling protein for oskar mRNA cytoplasmic localization [18, 19] . In Drosophila, localization of oskar mRNA at the posterior pole is essential and sufficient for the specification of the germline and the abdomen. Its posterior transport along the microtubules is mediated by kinesin I and several other proteins, such as Y14 and Mago-nashi, which, together with oskar mRNA, form a posterior localization complex. Human Y14 has also been shown to associate with mRNAs upon splicing and shuttles to the cytoplasm where it interacts with MAGOH, the human homolog of Mago-nashi [20, 21] . At the present time, there has been no report of an mRNA shuttling protein involved in the regulation of transcriptional factors, such as the nuclear shuttling of STATs.
Although the STATs show similar structural features, their nuclear-cytoplasmic localization has been shown to be differently regulated. After the importin-STAT1 complex enters the nucleus, importin is released from the complex and STAT1 can then bind to DNA [22, 23] . In contrast to STAT1, STAT3 has been shown to accumulate in the nucleus independent of its phosphorylation state [24] , although a reduction in BART as a novel STAT3 binding partner critical for the nuclear retention for STAT3 [25] . Therefore, it will be noteworthy to clarify the detailed interactions among STAT3, BART and Y14.
It will be very important to discover every step in the STAT3-specific regulation of gene transcription, since STAT3 may be a key player in the pathogenesis of diverse human diseases and an important target for novel therapies. Further understanding of the detailed molecular interactions between STAT3 and Y14 may provide a novel therapeutic strategy for STAT3-related human diseases. 
Figure legends
